HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 18 of 18
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
article (author version)Kibria, Golam; Hatakeyama, Hiroto; Sato, Yusuke; Harashima, HideyoshiAnti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors-International journal of pharmaceutics-25-Jul-2016
articleTamaru, Mina; Akita, Hidetaka; Nakatani, Taichi; Kajimoto, Kazuaki; Sato, Yusuke; Hatakeyama, Hiroto; Harashima, HideyoshiApplication of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain-International Journal of Nanomedicine-8-Sep-2014
article (author version)Ara, Mst Naznin; Matsuda, Takashi; Hyodo, Mamoru; Sakurai, Yu; Hatakeyama, Hiroto; Ohga, Noritaka; Hida, Kyoko; Harashima, HideyoshiAn aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells-Biomaterials-Aug-2014
article (author version)Takara, Kazuhiro; Hatakeyama, Hiroto; Ohga, Noritaka; Hida, Kyoko; Harashima, HideyoshiDesign of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake-INTERNATIONAL JOURNAL OF PHARMACEUTICS-30-Aug-2010
article (author version)Kibria, Golam; Hatakeyama, Hiroto; Ohga, Noritaka; Hida, Kyoko; Harashima, HideyoshiDual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery-Journal of Controlled Release-30-Jul-2011
article (author version)Kibria, Golam; Hatakeyama, Hiroto; Ohga, Noritaka; Hida, Kyoko; Harashima, HideyoshiThe effect of liposomal size on the targeted delivery of doxorubicin to Integrin alpha v beta 3-expressing tumor endothelial cells-Biomaterials-Jul-2013
articleHayashi, Yasuhiro; Suemitsu, Erina; Kajimoto, Kazuaki; Sato, Yusuke; Akhter, Afsana; Sakurai, Yu; Hatakeyama, Hiroto; Hyodo, Mamoru; Kaji, Noritada; Baba, Yoshinobu; Harashima, HideyoshiHepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes-Molecular Therapy - Nucleic Acids-18-Mar-2014
articleTakahashi, Mayumi; Yamada, Naoki; Hatakeyama, Hiroto; Murata, Manami; Sato, Yusuke; Minakawa, Noriaki; Harashima, Hideyoshi; Matsuda, AkiraIn vitro optimization of 2 '-OMe-4 '-thioribonucleoside-modified anti-microRNA oligonucleotides and its targeting delivery to mouse liver using a liposomal nanoparticle-Nucleic acids research-Dec-2013
articleTakahashi, Mayumi; Nagai, Chisato; Hatakeyama, Hiroto; Minakawa, Noriaki; Harashima, Hideyoshi; Matsuda, AkiraIntracellular stability of 2'-OMe-4'-thioribonucleoside modified siRNA leads to long-term RNAi effect-Nucleic Acids Research-Jul-2012
article (author version)Warashina, Shota; Nakamura, Takashi; Sato, Yusuke; Fujiwara, Yuki; Hyodo, Mamoru; Hatakeyama, Hiroto; Harashima, HideyoshiA lipid nanoparticle for the efficient delivery of siRNA to dendritic cells-Journal of controlled release-10-Mar-2016
article (author version)Akita, Hidetaka; Ishiba, Ryohei; Togashi, Ryohei; Tange, Kota; Nakai, Yuta; Hatakeyama, Hiroto; Harashima, HideyoshiA neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma-Journal of controlled release-28-Feb-2015
articleMaishi, Nako; Sakurai, Yu; Hatakeyama, Hiroto; Umeyama, Yui; Nakamura, Takashi; Endo, Rikito; Alam, Mohammad Towfik; Li, Cong; Annan, Dorcas Akuba-Muhyia; Kikuchi, Hiroshi; Morimoto, Hirofumi; Morimoto, Masahiro; Akiyama, Kosuke; Ohga, Noritaka; Hida, Yasuhiro; Harashima, Hideyoshi; Hida, KyokoNovel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system-Cancer science-9-Mar-2022
article (author version)Sato, Yusuke; Hatakeyama, Hiroto; Sakurai, Yu; Hyodo, Mamoru; Akita, Hidetaka; Harashima, HideyoshiA pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo-Journal of Controlled Release-10-Nov-2012
articleHatakeyama, Hiroto; Akita, Hidetaka; Harashima, HideyoshiThe Polyethyleneglycol Dilemma: Advantage and Disadvantage of PEGylation of Liposomes for Systemic Genes and Nucleic Acids Delivery to Tumors-Biological & Pharmaceutical Bulletin-Jun-2013
article (author version)Sato, Yusuke; Hatakeyama, Hiroto; Hyodo, Mamoru; Harashima, HideyoshiRelationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells-Molecular therapy-Apr-2016
article (author version)Sakurai, Yu; Hatakeyama, Hiroto; Sato, Yusuke; Hyodo, Mamoru; Akita, Hidetaka; Ohga, Noritaka; Hida, Kyoko; Harashima, HideyoshiRNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system-Journal of controlled release-10-Jan-2014
article (author version)Takara, Kazuhiro; Hatakeyama, Hiroto; Kibria, Golam; Ohga, Noritaka; Hida, Kyoko; Harashima, HideyoshiSize-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy-Journal of Controlled Release-20-Aug-2012
article (author version)Hatakeyama, Hiroto; Murata, Manami; Sato, Yusuke; Takahashi, Mayumi; Minakawa, Noriaki; Matsuda, Akira; Harashima, HideyoshiThe systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice-Journal of controlled release-10-Jan-2014
Showing results 1 to 18 of 18

 

Hokkaido University